Skip to main content
Screener/Healthcare/Biotechnology

NTLA — Intellia Therapeutics, Inc.

NASDAQ
$12.75-0.36 (-2.74%)
Small CapUnder $20HealthcareHigh Beta
$6.92
$28.25
$12.47
$13.01
EPS (TTM)$-3.54
P/E Ratio-3.47
Dividend Yield—
Market Cap$1.41B
Volume1.32M
Prev Close$13.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$15.0M-$96.2M$-0.810.0%-639.5%
Q4 '25$23.0M-$95.8M$-0.8373.9%-416.2%
Q3 '25$13.8M-$101.3M$-0.92-472.8%-735.2%
Q2 '25$14.2M-$101.3M$-0.98100.0%-710.8%
Q1 '25$16.6M-$114.3M$-1.10100.0%-687.6%
Q4 '24$12.9M-$128.9M$-1.27100.0%-1001.2%
Q3 '24$9.1M-$135.7M$-1.34100.0%-1489.5%
Q2 '24$7.0M-$147.0M$-1.5262.6%-2112.6%
Get Your Daily Market Recap
NTLA Stock Price, Chart & Analysis